HOUSTON, Aug. 25 US Oncology, Inc. today announced theappointment of Stephen Smith as Vice President/General Manager Research andPersonalized Science Services. Smith will oversee the US Oncology ResearchNetwork, which provides research management services to oncology practices andsites throughout the nationwide US Oncology Network.
The research network allows physicians to accelerate the availability anduse of scientific, evidence-based medicine and share best practices. It hasplayed a pivotal role in 24 of the last 30 cancer drugs approved by the FDAand more than 32,000 patients have participated in clinical trials.
Smith joins US Oncology from INC Research, Inc. where he was Senior VicePresident, Global Oncology. Prior to INC Research, he worked as CFO ofClinical Pharmacology and Labs for Pharmaceutical Product Development, Inc., amultinational healthcare technology and services firm. Smith served as anofficer in the United States Army for five years.
Smith earned a Bachelor of Science degree from the United States MilitaryAcademy, a Master of Science degree from the University of Northern Coloradoand a Master of Business Administration degree from Syracuse University,Whitman School of Management.
"We are excited to have Stephen as part of our team," said Bruce Broussard,president and chief executive officer of US Oncology. "Our research network isa strategic part of our mission to increase patient access to high-qualitycancer care. With Stephen's background and expertise we will further our goalof enhancing patient access to the latest investigational therapies."
"I am proud to be a part of US Oncology. Its continued commitment to sucha comprehensive research network and to advancing oncology research in novelways are important drivers of the innovative services US Oncology supports inall phases of the cancer care delivery system," said Smith.
Smith is based at the company's headquarters in Houston, Texas.
About US Oncology, Inc.
US Oncology, headquartered in Houston, works closely with physicians,manufacturers and payers to identify and deliver innovative services thatenhance patient access to advanced cancer care. US Oncology supports one ofthe nation's foremost cancer treatment and research networks accelerating theavailability and use of evidence-based medicine and shared best practices.
US Oncology's expertise in supporting every aspect of the cancer caredelivery system -- from drug development to treatment and outcomes measurement,enables the company to help increase the efficiency and safety of cancer care.According to the company's last quarterly earnings report, US Oncology isaffiliated with 1,247 physicians operating in 472 locations, including 91radiation oncology facilities in 39 states. For more information, visit thecompany's Web site, http://www.usoncology.com.
SOURCE US Oncology, Inc.